Personal information

Other IDs

Scopus Author ID: 57214790975

Activities

Collapse all

Works (11)

Prevalence and risk factors of trastuzumab induced cardiotoxicity in Tunisian HER2-positive breast cancer patients

Journal of Oncology Pharmacy Practice
2023-04 | Journal article
DOI: 10.1177/10781552221076407
Contributors: Imen Toukabri; Azza Ben Said; Adel Hamdi; Aziza Aloulou; Wiem Ben Ayed; Ines Cherif; Imen Limayem
Source: check_circle
Crossref

Incidence and risk factors associated with development of oxalipatin-induced acute peripheral neuropathy in colorectal cancer patients

Journal of Oncology Pharmacy Practice
2023-03 | Journal article
DOI: 10.1177/10781552211068138
Contributors: Imen Toukabri Ben Mahmoud; Azza Ben Said; Souad Berguiga; Racha Houij; Ines Cherif; Adel Hamdi; Wiem Ben Ayed; Imen Limayem
Source: check_circle
Crossref

Patterns of complementary and alternative medicine use among Tunisian cancer patients

Journal of Oncology Pharmacy Practice
2021-12 | Journal article
DOI: 10.1177/1078155220980131
Contributors: Imen Toukabri; Azza Ben Said; Adel Hamdi; Amina Mokrani; Azza Gabsi; Wiem Ben Ayed; Karawen Tounsi; Imen Limayem
Source: check_circle
Crossref

Risk management in chemotherapy preparation at the Salah Azaiz Institute, Tunis,Management du risque lié au processus de préparation des chimiothérapies à l'institut Salah Azaiz de Tunis

Pharmacien Hospitalier et Clinicien
2020 | Journal article
DOI: 10.1016/j.phclin.2019.05.002
EID:

2-s2.0-85079121740

Part of ISBN:

22111042
Contributors: Tlijani, M.; Thabti, A.; Hamdi, A.; Ben Said, A.; Limayem Blouza, I.
Source: Self-asserted source
Adel HAMDI via Scopus - Elsevier

Toxicity, risk factors and management of cisplatin-induced toxicity: A prospective study

Journal of Oncology Pharmacy Practice
2020 | Journal article
DOI: 10.1177/1078155219901305
EID:

2-s2.0-85079409460

Part of ISBN:

1477092X 10781552
Contributors: Ben Ayed, W.; Ben Said, A.; Hamdi, A.; Mokrani, A.; Masmoudi, Y.; Toukabri, I.; Limayem, I.; Yahyaoui, Y.
Source: Self-asserted source
Adel HAMDI via Scopus - Elsevier

Breast cancer T1 in an emerging country: 325 Tunisian cases

The Breast Journal
2020-10-13 | Journal article
DOI: 10.1111/tbj.14083
Part of ISSN: 1075-122X
Part of ISSN: 1524-4741
Source: Self-asserted source
Adel HAMDI

A practical approach to the management of colorectal cancer during the COVID-19 crisis in the reference cancer treatment center in Tunisia

Journal of Oncology Pharmacy Practice
2020-09-29 | Journal article
DOI: 10.1177/1078155220961139
Part of ISSN: 1078-1552
Part of ISSN: 1477-092X
Source: Self-asserted source
Adel HAMDI
grade
Preferred source (of 2)‎

Suggestion of Tunisia’s medical oncologist in the management of breast cancer during COVID-19 pandemic

Journal of Oncology Pharmacy Practice
2020-08-13 | Journal article
DOI: 10.1177/1078155220948943
Part of ISSN: 1078-1552
Part of ISSN: 1477-092X
Source: Self-asserted source
Adel HAMDI
grade
Preferred source (of 2)‎

Prognostic factors in High-Grade Localized Osteosarcoma of the Extremities: The Tunisian Experience

Journal of Orthopaedic Surgery
2020-05-01 | Journal article
DOI: 10.1177/2309499020974501
Part of ISSN: 2309-4990
Part of ISSN: 2309-4990
Source: Self-asserted source
Adel HAMDI
grade
Preferred source (of 2)‎

Summaries of the papers of the 4th National Congress of the Tunisian Society of Medical Oncology attached to the 4th Maghreb Congress of Oncology

La Tunisie medicale
2017 | Journal article
EID:

2-s2.0-85065592358

Part of ISBN:

00414131
Contributors: Abbes, I.; Abdelhak, S.; Abdelhedi, C.; Abid, K.; Abidi, R.; Acacha, E.; Achour, S.; Achour, A.; Adouni, O.; Afrit, M. et al.
Source: Self-asserted source
Adel HAMDI via Scopus - Elsevier

Comparaison de la néphrotoxicité du cisplatine administré en une dose unique versus dose divisée sur deux jours

Journal de Pharmacie de Belgique
Journal article
Source: Self-asserted source
Adel HAMDI
How many people are using ORCID?